SR One set to deploy $500m fund following GSK spin-out
Simeon George, CEO of life sciences investor SR One, speaks to Unquote about raising its first-time fund, the ongoing importance of its relationship with GSK following its spin-out from the company, and the firm's deal pipeline.
More on GPs
Searchlight hires new global head of value creation
Amanda Good joins from Hg as partner; she has prior experience with Bain & Company
Aurelius appoints Dränert in Wachstumskapital division
Markus Dränert will focus on software and technology investments, joining from his role at Finleap
Essling founder sells business to private investors
Frank-Noël Vandenberghe exits the business he co-founded with Michele Mezzarobba, who left last year
Buyout rankings: who invested the most in Europe in Q1 2021?
Unquote tallies the top 10 most active GPs across the European buyout space in the first quarter
Latest News
Searchlight hires new global head of value creation
Amanda Good joins from Hg as partner; she has prior experience with Bain & Company
IK closes third small-cap fund on €1.2bn hard-cap
New fund is more than double the size of its €550m predecessor, IK Small Cap II Fund, which is now almost fully invested
Lansdowne et al. in $120m round for TechMet
Company intends to launch a new round of funding later this year, with the goal of raising around $250m
Muzinich holds third close for second European debt fund
Private debt fund focuses on lower-mid-market companies; its predecessor closed on €706.5m in 2018